Geoffrey Guy
The Power List 2020 – R&D Trailblazers
Geoffrey Guy
Chairman and Founder, GW Pharmaceuticals, Cambridge, UK
Research: Creator of approved cannabinoid medicines Sativex and Epidiolex and leader of innovation and new product discovery at GW Pharmaceuticals. Physician in charge of over 300 clinical studies including first-dose-in-man, pharmacokinetics, pharmacodynamics, dose-ranging, controlled clinical trials and large-scale multi-centered studies and clinical surveys.
